|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/20/2024 |
$15.90 |
$15.90 |
$12.59 |
$13.01 |
21.10K | 03/21/2024 |
$13.00 |
$14.00 |
$13.00 |
$13.29 |
8.50K | 03/22/2024 |
$13.54 |
$13.90 |
$13.03 |
$13.03 |
3.00K | 03/25/2024 |
$12.53 |
$13.37 |
$12.17 |
$12.60 |
4.40K | 03/26/2024 |
$12.59 |
$12.59 |
$11.10 |
$11.10 |
3.70K |
|
AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology. | |
|
AgeX Therapeutics (AGE) has the following price history information. Looking back at AGE historical stock prices for the last five trading days, on March 20, 2024, AGE opened at $15.90, traded as high as $15.90 and as low as $12.59, and closed at $13.01. Trading volume was a total of 21.10K shares. On March 21, 2024, AGE opened at $13.00, traded as high as $14.00 and as low as $13.00, and closed at $13.29. Trading volume was a total of 8.50K shares. On March 22, 2024, AGE opened at $13.54, traded as high as $13.90 and as low as $13.03, and closed at $13.03. Trading volume was a total of 3.00K shares. On March 25, 2024, AGE opened at $12.53, traded as high as $13.37 and as low as $12.17, and closed at $12.60. Trading volume was a total of 4.40K shares. On March 26, 2024, AGE opened at $12.59, traded as high as $12.59 and as low as $11.10, and closed at $11.10. Trading volume was a total of 3.70K shares.
AGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/30/2018 |
|
End date: |
03/26/2024 |
|
Start price/share: |
$192.86 |
|
End price/share: |
$11.10 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.24% |
|
Average Annual Total Return: |
-41.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$575.38 |
|
Years: |
5.32 |
|
|
|
Date |
Close |
03/20/2024 | $13.01 | 03/21/2024 | $13.29 | 03/22/2024 | $13.03 | 03/25/2024 | $12.60 | 03/26/2024 | $11.10 |
|
|